ASRS
ANIP icon

Arizona State Retirement System’s ANI Pharmaceuticals ANIP Stock Holding History

Arizona State Retirement System’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Buy
5,022
+87
+2% +$6.98K ﹤0.01% 1619
2026
Q1 		$380K Sell
4,935
-66
-1% -$5.15K ﹤0.01% 1612
2025
Q4 		$395K Sell
5,001
-117
-2% -$10.1K ﹤0.01% 1621
2025
Q3 		$469K Buy
5,118
+89
+2% +$7.26K ﹤0.01% 1554
2025
Q2 		$328K Buy
5,029
+206
+4% +$13.4K ﹤0.01% 1690
2025
Q1 		$323K Sell
4,823
-50
-1% -$2.99K ﹤0.01% 1635
2024
Q4 		$269K Buy
4,873
+44
+0.9% +$2.53K ﹤0.01% 1813
2024
Q3 		$288K Buy
4,829
+127
+3% +$7.75K ﹤0.01% 1781
2024
Q2 		$299K Buy
4,702
+211
+5% +$13.7K ﹤0.01% 1705
2024
Q1 		$310K Buy
4,491
+238
+6% +$14.4K ﹤0.01% 1699
2023
Q4 		$235K Sell
4,253
-336
-7% -$18.5K ﹤0.01% 1870
2023
Q3 		$266K Buy
4,589
+415
+10% +$23.9K ﹤0.01% 1742
2023
Q2 		$225K Buy
+4,174
New +$185K ﹤0.01% 1891
2020
Q1 		– Sell
-6,203
Closed -$383K – 1842
2019
Q4 		$383K Sell
6,203
-4,716
-43% -$312K ﹤0.01% 1394
2019
Q3 		$796K Sell
10,919
-2,151
-16% -$161K 0.01% 1333
2019
Q2 		$1.07M Buy
13,070
+273
+2% +$19.4K 0.01% 1313
2019
Q1 		$903K Buy
12,797
+26
+0.2% +$1.53K 0.01% 1370
2018
Q4 		$575K Buy
12,771
+770
+6% +$40.4K 0.01% 1444
2018
Q3 		$679K Sell
12,001
-1,165
-9% -$71.3K 0.01% 1460
2018
Q2 		$879K Sell
13,166
-995
-7% -$62.1K 0.01% 1414
2018
Q1 		$824K Sell
14,161
-900
-6% -$57.1K 0.01% 1418
2017
Q4 		$971K Buy
15,061
+10,446
+226% +$650K 0.01% 1388
2017
Q3 		$242K Buy
+4,615
New +$220K ﹤0.01% 1450
2017
Q2 		– Sell
-4,115
Closed -$204K – 1499
2017
Q1 		$204K Hold
4,115
– – ﹤0.01% 1449
2016
Q4 		$249K Hold
4,115
– – ﹤0.01% 1420
2016
Q3 		$273K Buy
4,115
+200
+5% +$12.5K ﹤0.01% 1369
2016
Q2 		$219K Buy
+3,915
New +$190K ﹤0.01% 1401

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's ANIP Position: Q2 2026 in Review

Arizona State Retirement System increased its ANI Pharmaceuticals (ANIP) stake by 1.8% in Q2 2026, buying an estimated $6.98K and bringing the position to 5,022 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Arizona State Retirement System first reported a position in ANIP in Q2 2016 and has held it in 27 quarters since. The position peaked at $1.07M in Q2 2019. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Arizona State Retirement System held 5,022 shares of ANI Pharmaceuticals worth $416K as of Q2 2026.
  • Arizona State Retirement System bought 87 ANI Pharmaceuticals shares in Q2 2026, an estimated $6.98K.
  • ANI Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1619 holding.
  • Arizona State Retirement System first reported a position in ANI Pharmaceuticals in Q2 2016 and has held it in 27 quarters since.
  • Arizona State Retirement System's ANI Pharmaceuticals position peaked at $1.07M in Q2 2019.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.